SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 0.01%9.67B | -0.03%6.3B | -5.23%6.83B | -28.21%35.61B | -0.51%12.43B | -36.64%9.67B | -54.31%6.3B | -10.55%7.21B | 69.95%49.6B | 32.14%12.5B |
Net income from continuing operations | -31.41%4.5B | -26.05%4.44B | -15.96%5.55B | -39.87%21.41B | -64.83%2.24B | -41.67%6.56B | -48.72%6.01B | 5.23%6.61B | 126.96%35.61B | 25.50%6.38B |
Operating gains losses | 31.08%-1.07B | 5.52%-1.1B | -4.73%-1.64B | 49.39%-4.55B | 79.96%-277M | 45.35%-1.55B | 60.54%-1.16B | 14.81%-1.57B | -58.85%-9B | 15.68%-1.38B |
Depreciation and amortization | 0.79%4.23B | 17.59%4.19B | 13.44%4.12B | -2.00%14.99B | 3.36%3.6B | -0.59%4.2B | -6.32%3.56B | -4.17%3.63B | -10.10%15.3B | -9.39%3.49B |
Deferred tax | 450.43%403M | -32.34%454M | -12.91%688M | -85.97%298M | -353.14%-1.05B | -131.17%-115M | -6.15%671M | 26.20%790M | 203.43%2.12B | 81.58%414M |
Other non cash items | -189.52%-1.02B | 33.97%-276M | -23.60%-1.21B | 128.71%373M | 1,699.15%2.12B | -80.10%-353M | 38.89%-418M | -82.31%-979M | -34.75%-1.3B | 140.27%118M |
Change In working capital | 124.82%1.23B | 14.40%-2.7B | 27.85%-1.42B | -261.42%-3.34B | 41.08%1.23B | -67.07%548M | -824.60%-3.15B | -116.54%-1.96B | 224.46%2.07B | 87,500.00%874M |
-Change in receivables | 156.98%1.25B | -111.54%-330M | -138.76%-579M | 161.78%1.34B | 2.24%2.19B | -151.38%-2.19B | 95.37%-156M | 128.71%1.49B | 71.25%-2.16B | 218.92%2.14B |
-Change in inventory | 506.49%752M | -1,673.53%-535M | -35.03%-1.33B | 65.59%-320M | -34.19%816M | 86.60%-185M | 106.00%34M | -343.69%-985M | -75.47%-930M | 800.56%1.24B |
-Change in prepaid assets | -81.75%52M | 63.87%-211M | 131.02%255M | -431.86%-1.2B | -132.02%-81M | --285M | 5.19%-584M | -700.00%-822M | -1,289.47%-226M | 123.89%253M |
-Change in payables and accrued expense | -122.27%-615M | 41.50%-1.36B | 136.63%537M | -150.91%-2.85B | 31.50%-1.82B | 322.92%2.76B | -146.13%-2.33B | -133.04%-1.47B | -16.42%5.6B | -231.37%-2.65B |
-Change in other working capital | -68.85%-206M | -123.28%-259M | -62.16%-300M | -41.51%-300M | 210.81%123M | -777.78%-122M | -84.13%-116M | -230.36%-185M | 33.75%-212M | 27.45%-111M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 0.01%9.67B | -0.03%6.3B | -5.23%6.83B | -28.21%35.61B | -0.51%12.43B | -36.64%9.67B | -54.31%6.3B | -10.55%7.21B | 69.95%49.6B | 32.14%12.5B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 16.19%-3.7B | -0.25%-3.95B | -40.93%-3.96B | -25.80%-15.23B | -9.67%-4.07B | -59.38%-4.41B | 20.55%-3.94B | -322.11%-2.81B | -106.45%-12.11B | -167.24%-3.71B |
Capital expenditure reported | 13.22%-4.06B | -5.56%-3.97B | -34.60%-4.09B | -32.19%-15.83B | -13.72%-4.36B | -56.03%-4.67B | -18.00%-3.76B | -55.00%-3.04B | -48.63%-11.97B | -47.16%-3.84B |
Net business purchase and sale | -91.49%8M | -3.08%63M | -40.91%52M | 116.73%278M | -74.38%31M | 1,442.86%94M | 102.81%65M | -83.58%88M | -478.59%-1.66B | -70.91%121M |
Net investment purchase and sale | -102.29%-4M | --0 | -52.63%45M | 49.57%175M | 160.00%91M | 110.84%175M | -18,500.00%-186M | --95M | 11,800.00%117M | --35M |
Net other investing changes | 6,016.67%355M | 22.73%-51M | -25.00%36M | -89.79%144M | 609.09%168M | -103.95%-6M | -112.38%-66M | -93.68%48M | -19.51%1.41B | -104.12%-33M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 16.19%-3.7B | -0.25%-3.95B | -40.93%-3.96B | -25.80%-15.23B | -9.67%-4.07B | -59.38%-4.41B | 20.55%-3.94B | -322.11%-2.81B | -106.45%-12.11B | -167.24%-3.71B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 38.96%-5.26B | 47.82%-4.57B | 26.02%-4.86B | -20.54%-30.11B | 4.37%-6.17B | 4.48%-8.62B | -7.50%-8.75B | -381.19%-6.57B | -8.07%-24.98B | 22.21%-6.45B |
Net issuance payments of debt | 207.94%2.58B | 184.27%1.35B | 1,127.00%1.03B | 52.18%-4.06B | 111.36%35M | 4.92%-2.39B | 56.30%-1.6B | 95.00%-100M | 34.45%-8.48B | 94.87%-308M |
Net common stock issuance | -40.12%-4.75B | 31.41%-3B | 20.65%-2.98B | -32.73%-14.94B | 8.77%-3.42B | 9.60%-3.39B | -75.00%-4.38B | -199.04%-3.75B | -713.81%-11.26B | -400.00%-3.75B |
Cash dividends paid | -2.84%-2.93B | -5.68%-2.98B | -5.11%-3B | -3.36%-11.34B | -3.54%-2.81B | -3.97%-2.85B | -1.88%-2.82B | -4.04%-2.86B | -7.75%-10.97B | -5.69%-2.71B |
Proceeds from stock option exercised by employees | -35.71%36M | 102.86%71M | -40.41%87M | -95.53%261M | -92.79%24M | 5.66%56M | -95.68%35M | -96.85%146M | 310.84%5.84B | -67.76%333M |
Net other financing activities | -385.37%-199M | -133.33%-2M | 144.44%4M | 64.91%-40M | 136.36%4M | 38.81%-41M | 119.35%6M | -80.00%-9M | -216.67%-114M | -450.00%-11M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 38.96%-5.26B | 47.82%-4.57B | 26.02%-4.86B | -20.54%-30.11B | 4.37%-6.17B | 4.48%-8.62B | -7.50%-8.75B | -381.19%-6.57B | -8.07%-24.98B | 22.21%-6.45B |
Net cash flow | ||||||||||
Beginning cash position | -52.26%4.97B | -57.32%7.21B | -51.49%9.28B | 181.40%19.12B | -58.04%7.01B | -22.13%10.4B | 31.96%16.9B | 181.40%19.12B | 0.86%6.8B | 137.68%16.7B |
Current changes in cash | 121.32%716M | 65.22%-2.22B | 8.46%-1.99B | -177.76%-9.73B | -6.03%2.2B | -196.63%-3.36B | -1,040.44%-6.4B | -136.11%-2.18B | 5,888.52%12.52B | 1,157.47%2.34B |
Effect of exchange rate changes | 330.56%83M | 77.88%-23M | -53.19%-72M | 40.00%-114M | -16.09%73M | 73.13%-36M | 20.00%-104M | -261.54%-47M | -25.83%-190M | 1,066.67%87M |
End cash Position | -17.73%5.76B | -52.26%4.97B | -57.32%7.21B | -51.49%9.28B | -51.49%9.28B | -58.04%7.01B | -22.13%10.4B | 31.96%16.9B | 181.40%19.12B | 181.40%19.12B |
Free cash flow | 12.38%5.62B | -8.31%2.33B | -34.27%2.74B | -47.43%19.78B | -6.81%8.07B | -59.26%5B | -76.03%2.54B | -31.63%4.17B | 78.07%37.63B | 26.43%8.66B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |